Antibiotic treatment of chronic endometritis seems to preserve pregnancy in women with recurrent miscarriages or recurrent implantation failure

2018 ◽  
Author(s):  
S Meier ◽  
T Gillon ◽  
V Mitter ◽  
A Fink ◽  
M Mueller ◽  
...  
2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
A Vega. Carrill. d. Albornoz ◽  
E Carrill. D. Alborno. Riaza ◽  
Á Martíne. Acera ◽  
I Lópe. Carrasco ◽  
N Monter. Pastor ◽  
...  

Abstract Study question Does the treatment of chronic endometritis (CE) improve reproductive outcome in patients with recurrent implantation failure (RIF)? Summary answer Treatment and resolution of CE seem to improve pregnancy rates in patients with implantation failure and CE. What is known already Over the last 10 years, the interest in the study of CE has increased given its important association with reproductive failure. The main cause of CE is an infection of the endometrial cavity caused by common microorganisms. Therefore, the recommended treatment is antibiotic therapy. Numerous studies demonstrate an improvement in reproductive outcome in patients with treated and resolved CE. The objectives of this study are to evaluate the resolution rate of CE after antibiotic treatment in patients with implantation failure diagnosed with CE and to analyse their reproductive outcome after treatment. Study design, size, duration In this prospective case series, all patients with RIF who underwent diagnostic hysteroscopy, IHC analysis with CD138 of an endometrial biopsy and microbiological analysis of an endometrial sample between October 2018 and February 2019 were included. Participants/materials, setting, methods Hysteroscopic findings suggestive of CE were collected and endometrial biopsies were taken for pathological study with CD138 and microbiological assessment. Likewise, treated endometrial samples and the results of hysteroscopy or control biopsies after treatment were collected. The data of embryo transfers post-treatment were also included in our study. Main results and the role of chance 30 patients with implantation failure were included. 15 patients (50%) were diagnosed with CE using any of the aforementioned diagnostic methods. All diagnosed patients were treated with antibiotic therapy: positive microbiological samples (9) were treated according to our antibiogram whereas those samples who were negative but were confirmed to have CE by hysteroscopy or pathological assessment (6) were treated with doxycycline. In all cases, CE resolved after treatment, except only one patient who required a second course of antibiotics to acquire a negative result. Ten patients underwent an embryo transfer after resolution of CE, resulting in 60% of ongoing pregnancies. Limitations, reasons for caution Although our results are encouraging and in accordance with other studies, we are aware that this is an observational non-randomised study with a limited number of patients. Wider implications of the findings: It seems that the treatment of CE, following its diagnosis using the aforementioned methods, can improve pregnancy rates in patients with RIF and CE. Therefore, it is likely recommendable to study CE using these three tests. Trial registration number Not applicable


2010 ◽  
Vol 93 (2) ◽  
pp. 437-441 ◽  
Author(s):  
Erika B. Johnston-MacAnanny ◽  
Janice Hartnett ◽  
Lawrence L. Engmann ◽  
John C. Nulsen ◽  
M. Melinda Sanders ◽  
...  

2020 ◽  
Author(s):  
Kimiko Hirata ◽  
Fuminori Kimura ◽  
Akiko Nakamura ◽  
Jun Kitazawa ◽  
Aina Morimune ◽  
...  

Abstract Background: Chronic endometritis is a slight inflammation of the endometrium that is histologically diagnosed mainly by the presence of plasma cells in the endometrial stroma. In many previous clinical studies, the clinical outcomes were compared between the group cured with antibiotics and the persistent group, and the subjects were patients with recurrent implantation failure. However, antibiotics cannot be administered without establishing diagnostic criteria in advance. It is also difficult to purely evaluate the effect of chronic endometritis on implantation when the control group is defined as patients with recurrent implantation failure without chronic endometritis, since the pregnancy rate in patients with recurrent implantation failure will be lower due to the presence of causes other than chronic endometritis for implantation failure. For these reasons, there appear to be no uniform criteria based on clinical outcomes that are accepted worldwide.Methods:A prospective observational study was conducted in a single university from June 2014 to September 2017. Patients who underwent single frozen-thawed blastocyst transfer with a hormone replacement cycle after histological examination for the presence of chronic endometritis were enrolled. Participants with recurrent implantation failure, recurrent pregnancy loss, and diseases suspected to cause implantation failure were excluded. Four criteria were used to define chronic endometritis according to the number of plasma cells in the same group of patients: 1 or more plasma cells, 2 or more, 3 or more, or 5 or more in 10 high-power fields. Pregnancy rates, live birth rates, and miscarriage rates of the Non-chronic endometritis and the chronic endometritis groups defined with each criterion were calculated.Results: The pregnancy rate and live birth rate of Non- chronic endometritis was highest and all P values for pregnancy rates, live birth rates, and miscarriage rates were smallest when the diagnostic criterion of chronic endometritis was defined as the presence of one or more plasma cells in 10 high-power fields. Conclusion: Chronic endometritis should be diagnosed as the presence of one or more plasma cells in 10 high-power fields. According to this diagnostic criterion, chronic endometritis adversely affected the pregnancy rate and the live birth rate.


Sign in / Sign up

Export Citation Format

Share Document